The Committee for Medicinal Products for Human Use (CHMP) concluded that Foscan’ s effects on relieving the symptoms associated with advanced head and neck cancer were of interest.
Inimravimite komitee jõudis otsusele, et Foscani toime kaugelearenenud pea - ja kaelavähi sümptomite leevendamisel on huvipakkuv.